Eurobio Scientific SA (ALERS) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.28x

Eurobio Scientific SA (ALERS) has a Cash Flow Reinvestment Rate of 0.28x as of June 2025, reinvesting €1.50 Million (capex €1.50 Million ) from operating cash flow of €5.36 Million. Check cash flow quality index of Eurobio Scientific SA to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.28x
(Capex + Investments) / Operating CF

Total Reinvested

€1.50 Million
Capex + Investments

Operating Cash Flow

€5.36 Million
EUR

Capital Expenditures

€1.50 Million
EUR

Eurobio Scientific SA Cash Flow Reinvestment Rate (2017–2024)

Historical reinvestment intensity for Eurobio Scientific SA across 7 annual periods. Explore investment intensity of Eurobio Scientific SA to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Eurobio Scientific SA (2017–2024)

Year-by-year capital reinvestment analysis for Eurobio Scientific SA. For live market cap and broader valuation context, see Eurobio Scientific SA market capitalisation.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2024 0.84x €14.00 Million €16.70 Million €3.26 Million ▲ +413.0%
2023 0.16x €4.37 Million €26.77 Million €4.05 Million ▼ -95.1%
2022 3.36x €144.59 Million €43.07 Million €2.83 Million ▲ +2924.1%
2021 0.11x €7.32 Million €65.92 Million €1.85 Million ▲ +114.0%
2020 0.05x €2.85 Million €54.93 Million €2.30 Million ▼ -95.7%
2019 1.20x €5.98 Million €4.99 Million €1.59 Million ▼ -80.6%
2017 6.17x €15.27 Million €2.48 Million €3.91 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow